Dare Bioscience, Inc. (DARE) Total liabilities 2016–2025
Dare Bioscience, Inc. (DARE) total liabilities at each fiscal year-end, per SEC filings.
$29.6MFY2025 · since FY2016: $755,235 → $29.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.6M | +5.4% |
| FY2024 | $28.1M | +6.8% |
| FY2023 | $26.3M | -19.5% |
| FY2022 | $32.7M | +91.8% |
| FY2021 | $17.1M | — |
| FY2016 | $755,235 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DARE financial trends
DARE RevenueDARE Net incomeDARE Net marginDARE Gross profitDARE Gross marginDARE Operating incomeDARE Operating marginDARE Operating cash flowDARE Free cash flowDARE Capital expendituresDARE Return on equityDARE Stock buybacksDARE Dividends paidDARE Total assetsDARE Shareholders’ equityDARE overview →